MDxHealth (MDXH) Stock Sees Fair Value Cut As Analysts Weigh Dilution And Execution
BTIG Maintains Buy on MDxHealth, Lowers Price Target to $2
MDxHealth (MDXH) Q2 2026 Earnings Call Transcript
Lake Street Maintains Buy on MDxHealth, Lowers Price Target to $3
MDxHealth Says Well-Positioned to 'Return to Positive EBITDA'
MDxHealth S.A. Q2 2026 Earnings Call Summary
MDxHealth SA (MDXH) (Q2 2026) Earnings Call Highlights: Record Sequential Growth and Strategic ...
MDxHealth SA (MDXH) Reports Q2 Loss, Beats Revenue Estimates
Mdxhealth Reports Second Quarter 2026 Financial Results
MDxHealth SA (MDXH) Q2 2026 Earnings Call Transcript
Full Transcript: MDxHealth Q2 2026 Earnings Call
MDxHealth Affirms FY2026 Sales Guidance of $110.000M-$115.000M vs $98.814M Est
MDxHealth Q2 EPS $(0.18) Misses $(0.16) Estimate, Sales $27.200M Beat $25.884M Estimate
Mdxhealth to Release Second Quarter 2026 Financial Results on August 13
Mdxhealth Announces Receipt of Nasdaq Notification Regarding Minimum Market Value of Listed Securities Deficiency
MDxhealth Receives Nasdaq Noncompliance Notice
Mdxhealth Announces Receipt of Nasdaq Notification Regarding Minimum Bid Price Deficiency
Mdxhealth Receives Nasdaq Noncompliance Notice, Gets Time Through Dec. 28 To Regain Compliance
Mdxhealth Announces Peer-Reviewed Publication of Oxford GPS-ProMPT Study in European Urology Oncology, Establishing Scientific Foundation for the Landmark GPS-ProtecT Randomized Controlled Trial
MDXHealth Announces Peer-Reviewed Publication Of The Oxford GPS-ProMPT Study In the Journal 'European Urology Oncology'
Sign up for free to unlock this feature.
Creating your account...
Your account has been created. Redirecting...
Loading...
This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.